1-10 of 10
Martin R. Mueller, MD PhD
Close
Sort by
Journal Articles

Lck Is a Crucial Anergy Regulator in CLL

Alexander Fuchs, Melanie Märklin, PhD, Jonas Heitmann, Felicia Truckenmüller, Sebastian Jonas Saur, MD, Manuela Ganser, Stefanie Bugl, Ursula Kohlhofer, Leticia Quintanilla-Martinez, MD, Hans-Georg Kopp, MD, Lothar Kanz, Anjana Rao, PhD, Stefan Wirths, MD, Martin R. Mueller, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3003.
https://doi.org/10.1182/blood.V130.Suppl_1.3003.3003
Published: 2017
Journal Articles

Platelet Programmed Cell Death Ligand 1 (pPDL-1) Is a Prognostic Marker in Advanced Lung Cancer

Clemens Hinterleitner, MD, Jasmin Strähle, Stefan Wirths, MD, Stefanie Bugl, Elke Malenke, Martin R. Mueller, MD PhD, Lothar Kanz, Hans-Georg Kopp, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3610.
https://doi.org/10.1182/blood.V130.Suppl_1.3610.3610
Published: 2017
Journal Articles

Knock-Down of the NFAT2 Long and Intermediate Isoforms Leads to CLL Acceleration

Jonas S Heitmann, MD, Melanie Märklin, PhD, Posdorowkin Anastasia, B.Sc, Alexander R Fuchs, M.Sc., Felicia M Truckenmüller, Hans-Georg Kopp, MD, Lothar Kanz, MD, Anjana Rao, PhD, Stefan Wirths, MD, Martin R Mueller, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4371.
https://doi.org/10.1182/blood.V128.22.4371.4371
Published: 2016
Journal Articles

Loss of NFAT2 Leads to an Acceleration of Clonal Evolution in CLL

David J Müller, Melanie Märklin, PhD, Lothar Kanz, MD, Martin R Mueller, MD PhD, Stefan Wirths, MD
Journal: Blood
Blood (2016) 128 (22): 4369.
https://doi.org/10.1182/blood.V128.22.4369.4369
Published: 2016
Journal Articles

C-Cbl Regulates c-Mpl Receptor Trafficking and Its Internalization

Sebastian Jonas Saur, MD, Melanie Märklin, PhD, Manuela Ganser, Kyle Hoehn, James E David, PhD, Oliver Borst, MD, Lothar Kanz, MD, Hans-Georg Kopp, MD, Martin R Mueller, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2388.
https://doi.org/10.1182/blood.V126.23.2388.2388
Published: 2015
Journal Articles

Genetic Loss of NFAT2 Leads to CLL Transformation

Melanie Märklin, PhD, Jonas Heitmann, Felicia Truckenmüller, Lothar Kanz, MD, Sebastian Jonas Saur, MD, Manuela Ganser, Bugl Stefanie, PhD, Hans-Georg Kopp, MD, Michael Haap, MD, Anjana Rao, PhD, Stefan Wirths, MD, Martin R Mueller, MD PhD
Journal: Blood
Blood (2015) 126 (23): 364.
https://doi.org/10.1182/blood.V126.23.364.364
Published: 2015
Journal Articles

Hyperactivable NFAT1 Ameliorates Autoimmune Encephalitis In Vivo.

Srimoyee Ghosh, PhD, Sergei B Koralov, PhD, Irena Stevanovic, MD, Mark S Sundrud, PhD, Yoshiteru Sasaki, MD, PhD, Klaus Rajewsky, MD, Anjana Rao, PhD, Martin R Mueller, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 711.
https://doi.org/10.1182/blood.V114.22.711.711
Published: 2009
Journal Articles

Evidence for NFAT1 as a Tumor Suppressor in T-ALL

Martin R Mueller, MD, PhD, Bruno K Robbs, PhD, Andre LS Cruz, PhD, Yoshiteru Sasaki, MD, PhD, Irena Stevanovic, Klaus Rajewsky, MD, Joao PB Viola, PhD, Anjana Rao, PhD
Journal: Blood
Blood (2008) 112 (11): 3804.
https://doi.org/10.1182/blood.V112.11.3804.3804
Published: 2008
Journal Articles

Expression of Hyperactivable NFAT1 from the ROSA26 Locus Leads to Detrimental Effects during Embryonic Development.

Martin R. Mueller, MD, PhD, Yoshiteru Sasaki, MD, PhD, Sonia Sharma, PhD, Srimoyee Ghosh, PhD, Curtis Gelinas, Edward L. Lamperti, PhD, Klaus Rajewsky, MD, Anjana Rao, PhD
Journal: Blood
Blood (2007) 110 (11): 2296.
https://doi.org/10.1182/blood.V110.11.2296.2296
Published: 2007
Journal Articles

The Role of the Transcription Factor NFAT in the Pathogenesis of Non-Hodgkin’s Lymphomas.

Martin R. Mueller, MD, PhD, Yoshiteru Sasaki, MD, PhD, Sonia Sharma, PhD, Klaus Rajewsky, MD, Anjana Rao, PhD
Journal: Blood
Blood (2006) 108 (11): 2371.
https://doi.org/10.1182/blood.V108.11.2371.2371
Published: 2006